Neuronetics (STIM) Stock Fundamentals, Analysis & Risk Signals

Health score, price, valuation, risk signals, and key metrics at a glance.

Neuronetics

NasdaqGM•Healthcare•Medical Devices

$2.93+0.05(0.02%)Pre-market

Market Cap

$217.19M

P/S

1.4x

P/B

10.0x

Neuronetics, Inc. engages in providing in office treatments for patients with neurohealth disorders in the United States and internationally. The company provides NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. Neuronetics, Inc. has a strategic collaboration with ANT Neuro to expand the capabilities of the NeuroStar advanced therapy system with advanced image-guided navigation technology. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.

How this company scores

WeakMetricSide Score: 45/100

Grade capped at D — Interest coverage below 1× (-2.7x) — earnings cannot cover interest. Strongest: Growth (20/25); weakest: Balance Sheet & Red Flags (3/25).

Profitability15/25

Growth20/25

Balance Sheet & Red Flags3/25

Cash & Earnings Quality7/25

Strengths

Growing revenueProfit converts from growthConsistent growthImproving margins

Grade capped at D

Interest coverage below 1× (-2.7x) — earnings cannot cover interest.

Valuation vs. 5-year range

Today's multiple positioned against its own trailing range — a visual premium/discount check.

P/S · 1.4x5y range 0.3x – 2.5x

Currently above its 20-quarter median.

P/B · 10.0x5y range 0.3x – 10.0x

Currently above its 20-quarter median.

Watch items

Data-driven signals worth keeping an eye on across the last 8 quarters

High Risk

Margin Pressure

Red Flag

The company posted negative operating margins in recent quarters — core operations are unprofitable.

Earnings Quality

Red Flag

Free cash flow has been negative in 7 of the last 8 quarters — earnings are not translating to cash.

Price & Volume

Market Cap $217.19M

Metrics at a Glance

as of June 2026

Revenue & Profit

Revenue, EBITDA, operating income, net income, EPS, and shares

TTM Revenue: $155.10M
Q. Revenue: $41.57M
TTM EBITDA: $-19.73M
TTM Op. Income: $-22.86M
Q. Op. Income: $-1.50M
TTM Net Income: $-30.43M
Q. Net Income: $-3.44M
EPS: $-0.05
Shares Out.: $73.13M

$155.10M in TTM revenue grew 39.6% YoY, reaching $41.57M last quarter. TTM EBITDA of $-19.73M and TTM operating income of $-22.86M show growth is flowing through to the bottom line. However, net income is negative at $30.43M — growth is not yet reaching the bottom line. Across the last 8 quarters, TTM revenue has risen for 7 consecutive quarters — an improving trend.

Margins

Gross, EBITDA, operating, and net margin trends

Gross Margin: 51.1%
EBITDA Margin: -1.9%
Op. Margin: -3.6%
Net Margin: -8.3%

Op. margin of -3.6% is up 17.5% YoY — cost efficiency is improving. Net margin at -8.3% and gross margin of 51.1% show how much of each revenue dollar survives to profit. Over the past year, operating margin is up 83% — an improving trend.

Price Ratios

P/E, P/S, P/B, EV/EBITDA, FCF yield, and earnings yield

P/E Ratio: N/A
P/S Ratio: 1.4x
P/B Ratio: 10.0x

P/S of 1.4x and P/B of 10.0x. P/S is low relative to typical market levels.

Assets & Liabilities

Total assets, cash, debt, book value, and leverage

Total Assets: $131.53M
Cash: $19.20M
Long-Term Debt: $61.52M
Book Value: $21.64M
D/E Ratio: 2.8
Debt/EBITDA: N/A

With $131.53M in assets and $61.52M in long-term debt, D/E is 2.8and book value is $21.64M — elevated leverage, meaning significant financial risk in a downturn. Over the past year, debt/equity is up 61% — an improving trend.

Cash Flow

Operating cash flow, free cash flow, FCF margin, and earnings quality

Op. Cash Flow: $-1.01M
TTM Free Cash Flow: $-11.25M
FCF Margin: -7.3%
FCF / Net Income: 0.4

TTM FCF of $-11.25M on $-1.01M in operating cash flow. The FCF / Net Income ratio of 0.4x means cash covers only part of net income — earnings quality needs attention. Across the last 8 quarters, free cash flow has risen for 5 consecutive quarters — an improving trend.